Professor Golo Ahlenstiel

Journal Articles

• Shek, D., Gloss, B., Lai, J., Ma, L., Zhang, H., Carlino, M., Mahajan, H., Nagrial, A., Gao, B., Read, S. and Ahlenstiel, G. (2023), 'Identification and characterisation of infiltrating immune cells in malignant pleural mesothelioma using spatial transcriptomics', Methods and Protocols, vol 6, no 2 .
• Kalo, E., George, J., Read, S., Majumdar, A. and Ahlenstiel, G. (2023), 'Evolution of risk prediction models for post-operative mortality in patients with cirrhosis', Hepatology International, vol 17, no 3 , pp 542 - 545.
• Chen, H., Bhat, A., Gan, G., Khanna, S., Ahlenstiel, G., Negishi, K. and Tan, T. (2023), 'The impact of body mass index on cardiac structure and function in a cohort of obese patients without traditional cardiovascular risk factors', International Journal of Cardiology: Cardiovascular Risk and Prevention, vol 19 .
• Gupta, M., Balachandran, H., Louie, R., Li, H., Agapiou, D., Keoshkerian, E., Christ, D., Rawlinson, W., Mina, M., Post, J., Hudson, B., Gilroy, N., Konecny, P., Bartlett, A., Sasson, S., Ahlenstiel, G., Dwyer, D., Lloyd, A., Martinello, M., Luciani, F., Bull, R. and COSIN Study Group, .. (2023), 'High activation levels maintained in receptor-binding domain-specific memory B cells in people with severe coronavirus disease 2019', Immunology and Cell Biology, vol 101, no 2 , pp 142 - 155.
• Spirou, D., Raman, J., Leith, M., Collison, J., Bishay, R., Ahlenstiel, G., Hay, P. and Smith, E. (2022), 'The psychometric properties of the grazing questionnaire in an obesity sample with and without binge eating disorder', Journal of Eating Disorders, vol 10, no 1 .
• Spirou, D., Raman, J., Bishay, R., Ahlenstiel, G. and Smith, E. (2022), 'Childhood trauma, posttraumatic stress disorder symptoms, early maladaptive schemas, and schema modes : a comparison of individuals with obesity and normal weight controls', BMC Psychiatry, vol 22, no 1 .
• Maharaj, A., Lubel, J., Lam, E., Clark, P., Duncan, O., George, J., Jeffrey, G., Lipton, L., Liu, H., McCaughan, G., Neo, E., Philip, J., Strasser, S., Stuart, K., Thompson, A., Tibballs, J., Tu, T., Wallace, M., Wigg, A., Wood, M., Zekry, A., Greenhill, E., Ioannou, L., Ahlenstiel, G., Bowers, K., Clarke, S., Dev, A., Fink, M., Goodwin, M., Karapetis, C., Levy, M., Muller, K., O'Beirne, J., Pryor, D., Seow, J., Shackel, N., Tallis, C., Butler, N., Olynyk, J., Reed-Cox, K., Zalcberg, J. and Roberts, S. (2022), 'Monitoring quality of care in hepatocellular carcinoma : a modified Delphi consensus', Hepatology Communications, vol 6, no 11 , pp 3260 - 3271.
• Kalo, E., Read, S. and Ahlenstiel, G. (2022), 'Reprogramming : evolving path to functional surrogate ?-Cells', Cells, vol 11, no 18 .
• Wijaya, R., Read, S., Truong, N., Han, S., Chen, D., Shahidipour, H., Fewings, N., Schibeci, S., Azardaryany, M., Parnell, G., Booth, D., Poorten, D., Lin, R., George, J., Douglas, M. and Ahlenstiel, G. (2021), 'HBV vaccination and HBV infection induces HBV-specific natural killer cell memory', Hepatology, vol 70, no 2 , pp 357 - 369.
• Wijaya, R., Read, S., Selvamani, S., Schibeci, S., Azardaryany, M., Ong, A., Poorten, D., Lin, R., Douglas, M., George, J. and Ahlenstiel, G. (2021), 'Hepatitis C virus eradication with interferon free, DAA-based therapy results in KLRGI+, hepatitis C virus-specific memory natural killer cells', Journal of Infectious Diseases, vol 223, no 7 , pp 1183 - 1195.
• Chimoriya, R., Piya, M., Simmons, D., Ahlenstiel, G. and Ho, V. (2021), 'The use of two-dimensional shear wave elastography in people with obesity for the assessment of liver fibrosis in non-alcoholic fatty liver disease', Journal of Clinical Medicine, vol 10, no 1 .
• Wijaya, R., Read, S., Schibeci, S., Han, S., Azardaryany, M., Van Der Poorten, D., Lin, R., Yuen, L., Lam, V., Douglas, M., George, J. and Ahlenstiel, G. (2021), 'Expansion of dysfunctional CD56-CD16+ NK cells in chronic hepatitis B patients', Liver International, vol 41, no 5 , pp 969 - 981.
• Tannous, K., Ahmed, M., John, J., Reece, G. and Ahlenstiel, G. (2021), 'Estimating the economic burden of low health literacy in the Blacktown community in Sydney, Australia : a population-based study', International Journal of Environmental Research and Public Health, vol 18, no 5 .
• Cheema, M., Mitrev, N., Hall, L., Tiongson, M., Ahlenstiel, G. and Kariyawasam, V. (2021), 'Depression, anxiety and stress among patients with inflammatory bowel disease during the COVID-19 pandemic : Australian national survey', BMJ Open Gastroenterology, vol 8, no 1 .
• Williams, A., Paramsothy, R., Wu, N., Ghaly, S., Leach, S., Paramsothy, S., Corte, C., O'Brien, C., Burke, C., Wark, G., Samocha-Bonet, D., Lambert, K., Ahlenstiel, G., Wasinger, V., Dutt, S., Pavli, P., Grimm, M., Lemberg, D., Connor, S., Leong, R. and Hold, G. (2021), 'Australia IBD microbiome (AIM) study : protocol for a multicentre longitudinal prospective cohort study', BMJ Open, vol 11, no 2 .
• Papaluca, T., Roberts, S., Strasser, S., Stuart, K., Farrell, G., MacQuillan, G., Dore, G., Wade, A., George, J., Hazeldine, S., O'Beirne, J., Wigg, A., Fisher, L., McGarity, B., Sawhney, R., Sinclair, M., Thomas, J., Valiozis, I., Weltman, M., Wilson, M., Woodward, A., Ahlenstiel, G., Haque, M., Levy, M., Prewett, E., Sievert, W., Sood, S., Tse, E., Valaydon, Z., Bowden, S., Douglas, M., New, K., O'Keefe, J., Hellard, M., Doyle, J., Stoove, M. and Thompson, A. (2021), 'Efficacy and safety of sofosbuvir/velpatasvir/voxilaprevir for HCV NS5A-inhibitor experienced patients with difficult to cure characteristics', Clinical Infectious Diseases, vol 73, no 9 , pp 3288 - 3295.
• Awadie, H., Klein, A., Tate, D., Jideh, B., Bar-Yishai, I., Goodrick, K., Ahlenstiel, G. and Bourke, M. (2021), 'The prevalence of small-bowel polyps on video capsule endoscopy in patients with sporadic duodenal or ampullary adenomas', Gastrointestinal Endoscopy, vol 93, no 3 , pp 630 - 636.
• Shek, D., Read, S., Nagrial, A., Carlino, M., Gao, B., George, J. and Ahlenstiel, G. (2021), 'Immune-checkpoint inhibitors for advanced hepatocellular carcinoma : a synopsis of response rates', The Oncologist, vol 26, no 7 , pp 1216 - 1225.
• Bishay, R., Meyerowitz-Katz, G., Hng, T., Colaco, C., Khanna, S., Klein, R., Sanjeev, D., McLean, M., Ahlenstiel, G. and Maberly, G. (2021), 'A retrospective case-control cohort analysis of comorbidity and health expenditure in hospitalized adults diagnosed with obesity utilizing ICD-10 diagnostic coding', Clinical Obesity, vol 11, no 5 .
• Read, S., Gloss, B., Liddle, C., George, J. and Ahlenstiel, G. (2021), 'Interferon-[lambda]3 exacerbates the inflammatory response to microbial ligands : implications for SARS-CoV-2 pathogenesis', Journal of Inflammation Research, vol 14 , pp 1257 - 1270.
• Shek, D., Chen, D., Read, S. and Ahlenstiel, G. (2021), 'Examining the gut-liver axis in liver cancer using organoid models', Cancer Letters, vol 510 , pp 48 - 58.
• Driscoll, S., Meyerowitz-Katz, G., Ahlenstiel, G., Reynolds, T., Reid, K. and Bishay, R. (2021), 'Efficacy of telephone health coaching integration with standard multidisciplinary care for adults with obesity attending a weight management service : a pilot study', Nutrients, vol 13, no 11 .
• Shek, D., Akhuba, L., Carlino, M., Nagrial, A., Moujaber, T., Read, S., Gao, B. and Ahlenstiel, G. (2021), 'Immune-checkpoint inhibitors for metastatic colorectal cancer : a systematic review of clinical outcomes', Cancers, vol 13, no 17 .
• Njiomegnie, G., Read, S., Fewings, N., George, J., McKay, F. and Ahlenstiel, G. (2020), 'Immunomodulation of the natural killer cell phenotype and response during HCV infection', Journal of Clinical Medicine, vol 9, no 4 .
• Nguyen, R., Bae, S., Zhou, G., Read, S., Ahlenstiel, G., George, J. and Qiao, L. (2020), 'Application of organoids in translational research of human diseases with a particular focus on gastrointestinal cancers', Biochimica et Biophysica Acta: Reviews on Cancer, vol 1873, no 2 .
• Shek, D., Read, S., Akhuba, L., Qiao, L., Gao, B., Nagrial, A., Carlino, M. and Ahlenstiel, G. (2020), 'Non-coding RNA and immune-checkpoint inhibitors : friends or foes?', Immunotherapy, vol 12, no 7 , pp 513 - 529.
• Sasson, S., Zaunders, J., Nahar, K., Munier, C., Fairfax, B., Olsson-Brown, A., Jolly, C., Read, S., Ahlenstiel, G., Palendira, U., Scolyer, R., Carlino, M., Payne, M., Cheung, V., Gupta, T., Klenerman, P., Long, G., Brain, O., Menzies, A. and Kelleher, A. (2020), 'Mucosal-associated invariant T (MAIT) cells are activated in the gastrointestinal tissue of patients with combination ipilimumab and nivolumab therapy-related colitis in a pathology distinct from ulcerative colitis', Clinical and Experimental Immunology, vol 202, no 3 , pp 335 - 352.
• Kreuter, R., Wankell, M., Ahlenstiel, G. and Hebbard, L. (2019), 'The role of obesity in inflammatory bowel disease', Biochimica et Biophysica Acta. Molecular Basis of Disease, vol 1865, no 1 , pp 63 - 72.
• Read, S., Obeid, S., Ahlenstiel, C. and Ahlenstiel, G. (2019), 'The role of zinc in antiviral immunity', Advances in Nutrition, vol 10, no 4 , pp 696 - 710.
• Eslam, M., Ahlenstiel, G. and George, J. (2019), 'Interferon lambda and liver fibrosis', Journal of Interferon and Cytokine Research, vol 39, no 10 , pp 627 - 635.
• Shek, D., Read, S., Ahlenstiel, G. and Piatkov, I. (2019), 'Pharmacogenetics of anticancer monoclonal antibodies', Cancer Drug Resistance, vol 2 , pp 69 - 81.
• Wijaya, R., Read, S., Schibeci, S., Eslam, M., Azardaryany, M., El-Khobar, K., Van der Poorten, D., Lin, R., Yuen, L., Lam, V., George, J., Douglas, M. and Ahlenstiel, G. (2019), 'KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B', Journal of Hepatology, vol 71, no 2 , pp 252 - 264.
• Gupta, S., Read, S., Shackel, N., Hebbard, L., George, J. and Ahlenstiel, G. (2019), 'The role of micronutrients in the infection and subsequent response to hepatitis C virus', Cells, vol 8, no 6 .
• Chen, D., Le, T., Shahidipour, H., Read, S. and Ahlenstiel, G. (2019), 'The role of gut-derived microbial antigens on liver fibrosis initiation and progression', Cells, vol 8, no 11 .
• Read, S., Wijaya, R., Ramezani-Moghadam, M., Tay, E., Schibeci, S., Liddle, C., Lam, V., Yuen, L., Douglas, M., Booth, D., George, J. and Ahlenstiel, G. (2019), 'Macrophage coordination of the interferon lambda immune response', Frontiers in Immunology, vol 10 .
• Yee, C., Main, N., Terry, A., Stevanovski, I., Maczurek, A., Morgan, A., Calabro, S., Potter, A., Iemma, T., Bowen, D., Ahlenstiel, G., Warner, F., McCaughan, G., McLennan, S. and Shackel, N. (2019), 'CD147 mediates intrahepatic leukocyte aggregation and determines the extent of liver injury', PLoS One, vol 14, no 7 .
• Read, S., Parnell, G., Booth, D., Douglas, M., George, J. and Ahlenstiel, G. (2018), 'The antiviral role of zinc and metallothioneins in hepatitis C infection', Journal of Viral Hepatitis, vol 25, no 5 , pp 491 - 501.
• Van Der Poorten, D., McLeod, D., Ahlenstiel, G., Read, S., Kwok, A., Santhakumar, C., Bassan, M., Culican, S., Campbell, D., Wong, S., Evans, L., Jideh, B., Kane, A., Katelaris, C., Keat, K., Ko, Y., Lee, J., Limaye, S., Lin, M., Murad, A., Rafferty, M., Suan, D., Swaminathan, S., Riminton, S., Toong, C. and Berglund, L. (2018), 'Gastric cancer screening in common variable immunodeficiency', Journal of Clinical Immunology, vol 38, no 7 , pp 768 - 777.
• Read, S., O'Connor, K., Suppiah, V., Ahlenstiel, C., Obeid, S., Cook, K., Cunningham, A., Douglas, M., Hogg, P., Booth, D., George, J. and Ahlenstiel, G. (2017), 'Zinc is a potent and specific inhibitor of IFN-3 signalling', Nature Communications, vol 8 .
• Desomer, L., Tate, D., Awadie, H., Pillay, L., Ahlenstiel, G. and Bourke, M. (2017), 'Persistent pain after colonic endoscopic mucosal resection : predictors, a management algorithm and outcomes', Gastrointestinal Endoscopy, vol 85, no 5S , pp 421 - 421.
• Obeid, S., Wankell, M., Charrez, B., Sternberg, J., Kreuter, R., Esmaili, S., Ramezani-Moghadam, M., Devine, C., Read, S., Bhathal, P., Lopata, A., Ahlenstiel, G., Qiao, L., George, J. and Hebbard, L. (2017), 'Adiponectin confers protection from acute colitis and restricts a B cell immune response', Journal of Biological Chemistry, vol 292, no 16 , pp 6569 - 6582.
• Klein, A., Ahlenstiel, G., Tate, D., Burgess, N., Richardson, A., Pang, T., Byth, K. and Bourke, M. (2017), 'Endoscopic resection of large duodenal and papillary lateral spreading lesions is clinically and economically advantageous compared with surgery', Endoscopy, vol 49, no 7 , pp 659 - 667.
• Mah, X., Gupta, V., Loch, S., Ahlenstiel, G. and Van Der Poorten, D. (2017), 'Compounded levofloxacin triple therapy is safe and effective for refractory Helicobacter pylori', International Journal of Pharmaceutical Compounding, vol 21, no 4 , pp 330 - 333.
• Klein, A., Gizbar, M., Bourke, M. and Ahlenstiel, G. (2016), 'Validated computed cleansing score for video capsule endoscopy', Digestive Endoscopy, vol 28, no 5 , pp 564 - 569.
• Eslam, M., Hashem, A., Romero-Gomez, M., Berg, T., Dore, G., Mangia, A., Chan, H., Irving, W., Sheridan, D., Abate, M., Adams, L., Weltman, M., Bugianesi, E., Spengler, U., Shaker, O., Fischer, J., Mollison, L., Cheng, W., Nattermann, J., Riordan, S., Miele, L., Kelaeng, K., Ampuero, J., Ahlenstiel, G., McLeod, D., Powell, E., Liddle, C., Douglas, M., Booth, D. and George, J. (2016), 'FibroGENE : a gene-based model for staging liver fibrosis', Journal of Hepatology, vol 64, no 2 , pp 390 - 398.
• O'Connor, K., Read, S., Wang, M., Schibeci, S., Eslam, M., Ong, A., Weltman, M., Douglas, M., Mazzola, A., Craxi, A., Petta, S., Stewart, G., Liddle, C., George, J., Ahlenstiel, G. and Booth, D. (2016), 'IFNL3/4 genotype is associated with altered immune cell populations in peripheral blood in chronic hepatitis C infection', Genes and Immunity, vol 17, no 6 , pp 328 - 334.
• Read, S., Ramezani-Moghadam, M., Schibeci, S., George, J. and Ahlenstiel, G. (2016), 'Interferon lambda drives a pro-inflammatory phenotype in macrophages', European Journal of Immunology, vol 46, no Suppl. 1 , pp 438 - 438.
• Pellise, M., Burgess, N., Bahin, F., Ahlenstiel, G., Sonson, R., Williams, S., Lee, E., McLeod, D., Mahajan, H. and Bourke, M. (2015), 'Extended wide field endoscopic mucosal resection does not reduce recurrence compared to standard endoscopic mucosal resection of large colonic laterally spreading lesions', Gastrointestinal Endoscopy, vol 81, no 5S , pp 168 - 169.
• Garcia, M., Ahlenstiel, G., Mahajan, H. and Van Der Poorten, D. (2015), 'Small bowel varices secondary to chronic superior mesenteric vein thrombosis in a patient with heterozygous Factor V Leiden mutation : a case report', Journal of Medical Case Reports, vol 9, no 1 .
• Musumba, C., Hsu, C., Ahlenstiel, G., Tutticci, N., Nanda, K., Van Der Poorten, D., Lee, E. and Kwan, V. (2015), 'Feasibility and safety of overtubes for PEG-tube placement in patients with head and neck cancer', Gastroenterology Research and Practice, vol 2015 .
• Dold, L., Ahlenstiel, G., Althausen, E., Luda, C., Schwarze-Zander, C., Boesecke, C., Wasmuth, J., Rockstroh, J. and Spengler, U. (2015), 'Survival and HLA-B*57 in HIV/HCV co-infected patients on highly active antiretroviral therapy (HAART)', PLoS One, vol 10, no 8 .
• Eslam, M., Hashem, A., Leung, R., Romero-Gomez, M., Berg, T., Dore, G., Chan, H., Irving, W., Sheridan, D., Abate, M., Adams, L., Mangia, A., Weltman, M., Bugianesi, E., Spengler, U., Shaker, O., Fischer, J., Mollison, L., Cheng, W., Powell, E., Nattermann, J., Riordan, S., McLeod, D., Armstrong, N., Douglas, M., Liddle, C., Booth, D., George, J. and Ahlenstiel, G. (2015), 'Interferon-rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease', Nature Communications, vol 6 .
• Beard, M., Ffrench, R., Gowans, E., Helbig, K., Eyre, N., Douglas, M., Grebely, J., Ahlenstiel, G., Locarnini, S., George, J., Shackel, N., White, P., Thompson, A. and Drummer, H. (2014), 'A summary of the 20th International Symposium on Hepatitis C Virus and Related Viruses', Gastroenterology, vol 147, no 1 , pp 1 - 4.
• O'Connor, K., Parnell, G., Patrick, E., Ahlenstiel, G., Suppiah, V., Van Der Poorten, D., Read, S., Leung, R., Douglas, M., Yang, Y., Stewart, G., Liddle, C., George, J. and Booth, D. (2014), 'Hepatic metallothionein expression in chronic hepatitis C virus infection is IFNL3 genotype-dependent', Genes and Immunity, vol 15, no 2 , pp 88 - 94.
• Musumba, C., Hsu, C., Ahlenstiel, G., Tutticci, N., Nanda, K., Van Der Poorten, D., Lee, E. and Kwan, V. (2014), 'Safety and efficacy of overtubes for preventing cutaneous metastasis during PEG tube placement in patients with head and neck cancer : a single-center study', Gastrointestinal Endoscopy, vol 79, no 5S , pp 280 - 280.
• Rotman, Y., Noureddin, M., Feld, J., Guedj, J., Witthaus, M., Han, H., Park, Y., Park, S., Heller, T., Ghany, M., Doo, E., Koh, C., Abdalla, A., Gara, N., Sarkar, S., Thomas, E., Ahlenstiel, G., Edlich, B., Titerence, R., Hogdal, L., Rehermann, B., Dahari, H., Perelson, A., Hoofnagle, J. and Liang, T. (2014), 'Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C', Gut, vol 63, no 1 , pp 161 - 169.
• O'Connor, K., George, J., Booth, D. and Ahlenstiel, G. (2014), 'Dendritic cells in hepatitis C virus infection : key players in the IFNL3-genotype response', World Journal of Gastroenterology, vol 20, no 47 , pp 17830 - 17838.
• O'Connor, K., Ahlenstiel, G., Suppiah, V., Schibeci, S., Ong, A., Leung, R., Van Der Poorten, D., Douglas, M., Weltman, M., Stewart, G., Liddle, C., George, J. and Booth, D. (2014), 'IFNL3 mediates interaction between innate immune cells : implications for hepatitis C virus pathogenesis', Innate Immunity, vol 20, no 6 , pp 598 - 605.
• Eslam, M., Leung, R., Romero-Gomez, M., Mangia, A., Irving, W., Sheridan, D., Spengler, U., Mollison, L., Cheng, W., Bugianesi, E., McLeod, D., Zaitoun, A., Attino, V., Goeltz, D., Nattermann, J., Douglas, M., Booth, D., George, J. and Ahlenstiel, G. (2014), 'IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection', Journal of Hepatology, vol 61, no 2 , pp 235 - 241.
• Ahlenstiel, G., Hourigan, L., Brown, G., Zanati, S., Williams, S., Singh, R., Moss, A., Sonson, R. and Bourke, M. (2014), 'Actual endoscopic versus predicted surgical mortality for treatment of advanced mucosal neoplasia of the colon', Gastrointestinal Endoscopy, vol 80, no 4 , pp 668 - 676.
• O'Day, R., Ahlenstiel, G., Shetty, A., Favaloro, E., Williams, S. and Koutts, J. (2014), 'Artefactual "in-vitro coagulopathy" in a patient with non-Hodgkin lymphoma and lower gastrointestinal bleeding', Medical Journal of Australia, vol 200, no 5 , pp 293 - 294.
• Werner, J., Serti, E., Chepa-Lotrea, X., Stoltzfus, J., Ahlenstiel, G., Noureddin, M., Feld, J., Liang, T., Rotman, Y. and Rehermann, B. (2014), 'Ribavirin improves the IFN-Y response of natural killer cells to IFN-based therapy of hepatitis C virus infection', Hepatology, vol 60, no 4 , pp 1160 - 1169.
• Eslam, M., Booth, D., George, J. and Ahlenstiel, G. (2013), 'Interaction of IFNL3 with insulin resistance, steatosis and lipid metabolism in chronic hepatitis C virus infection', World Journal of Gastroenterology, vol 19, no 41 , pp 7055 - 7061.
• Ahlenstiel, G. (2013), 'The natural killer cell response to HCV infection', Immune Network, vol 13, no 5 , pp 168 - 176.
• Ahlenstiel, G., Sonson, R. and Bourke, M. (2013), 'Diagnosis and treatment of radiation proctitis', Video Journal and Encyclopedia of GI Endoscopy, vol 1, no 2 , pp 316 - 317.
• O'Day, R., Gillies, M. and Ahlenstiel, G. (2013), 'Ophthalmologic complications of antiviral therapy in hepatitis C treatment', World Journal of Gastroenterology, vol 19, no 45 , pp 8227 - 8237.
• Suppiah, V., Armstrong, N., O'Connor, K., Berg, T., Weltman, M., Abate, M., Spengler, U., Bassendine, M., Dore, G., Irving, W., Powell, E., Nattermann, J., Mueller, T., Riordan, S., Stewart, G., George, J., Booth, D. and Ahlenstiel, G. (2013), 'CCR5-32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infection', Genes and Immunity, vol 14, no 5 , pp 286 - 290.
• Booth, D., Ahlenstiel, G. and George, J. (2012), 'Pharmacogenomics of hepatitis C infections : personalizing therapy', Genome Medicine, vol 4, no 12 .
• Ahlenstiel, G., Booth, D. and George, J. (2012), 'Will IL28B polymorphisms remain relevant to direct-acting antiviral treatment paradigms?', Antiviral Therapy, vol 17 , pp 1163 - 1170.
• Edlich, B., Ahlenstiel, G., Azpiroz, A., Stoltzfus, J., Noureddin, M., Serti, E., Feld, J., Liang, J., Rotman, Y. and Rehermann, B. (2012), 'Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients', Hepatology, vol 55, no 1 , pp 39 - 48.
• Ahlenstiel, G., Booth, D. and George, J. (2011), 'Clinical significance of IL28B gene variation in hepatitis C virus infection', Hot Topics in Viral Hepatitis, vol 7, no 20 , pp 17 - 24.
• Suppiah, V., Gaudieri, S., Armstrong, N., O'Connor, K., Berg, T., Weltman, M., Abate, M., Spengler, U., Bassendine, M., Dore, G., Irving, W., Powell, E., Hellard, M., Riordan, S., Mathews, G., Sheridan, D., Nattermann, J., Smedile, A., Muller, T., Hammond, E., Dunn, D., Negro, F., Bochud, P., Mallai, S., Ahlenstiel, G., Stewart, G., George, J. and Booth, D. (2011), 'IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European cohort : a cross-sectional study', PLoS Medicine, vol 8, no 9 .
• Ahlenstiel, G., Edlich, B., Hogdal, L., Rotman, Y., Noureddin, M., Feld, J., Holz, L., Titerence, R., Liang, T. and Rehermann, B. (2011), 'Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C', Gastroenterology, vol 141, no 4 , pp 1231 - 1239.
• Feld, J., Modi, A., El?Diwany, R., Rotman, Y., Thomas, E., Ahlenstiel, G., Titerence, R., Koh, C., Cherepanov, V., Heller, T., Ghany, M., Park, Y., Hoofnagle, J. and Liang, T. (2011), 'S-adenosyl methionine improves early viral responses and interferon-stimulated gene induction in hepatitis C nonresponders', Gastroenterology, vol 140, no 3 , pp 830 - 839.
• Smith, K., Suppiah, V., O'Connor, K., Berg, T., Weltman, M., Abate, M., Spengler, U., Bassendine, M., Matthews, G., Irving, W., Powell, E., Riordan, S., Ahlenstiel, G., Stewart, G., Bahlo, M., George, J. and Booth, D. (2011), 'Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort', Genome Medicine, vol 3 .
• Ahlenstiel, G., Bourke, M., Moss, A., Williams, S., Hourigan, L., Brown, G., Singh, R., Tam, W. and Chen, R. (2010), 'Actual endoscopic vs predicted surgical mortality for the treatment of large (> 20 Mm) laterally spreading tumors (LSTS) and sessile lesions of the colon : outcomes from a large, prospective multicenter trial', Gastroenterology, vol 138, no 5 , pp 635 - 636.
• Ahlenstiel, G., Booth, D. and George, J. (2010), 'IL28B in hepatitis C virus infection : translating pharmacogenomics into clinical practice', Journal of Gastroenterology, vol 45, no 9 , pp 903 - 910.
• Vogel, M., Ahlenstiel, G., Hintsche, B., Fenske, S., Trein, A., Lutz, T., Schurmann, D., Stephan, C., Khaykin, P., Bickel, M., Mayr, C., Baumgarten, A., Buggisch, P., Klinker, H., John, C., Golz, J., Staszewski, S. and Rockstroh, J. (2010), 'The influence of HAART on the efficacy and safety of pegylated interferon and ribavirin therapy for the treatment of chronic HCV infection in HIV-positive individuals', European Journal of Medical Research, vol 15, no 3 , pp 102 - 111.
• Ahlenstiel, G., Titerence, R., Koh, C., Edlich, B., Feld, J., Rotman, Y., Ghany, M., Hoofnagle, J., Liang, T., Heller, T. and Rehermann, B. (2010), 'Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner', Gastroenterology, vol 138, no 1 , pp 325 - 335.
• Yoon, J., Shiina, M., Ahlenstiel, G. and Rehermann, B. (2009), 'Natural killer cell function is intact after direct exposure to infectious hepatitis C virions', Hepatology, vol 49, no 1 , pp 12 - 21.
• Ahlenstiel, G., Woitas, R., Iwan, A., Nattermann, J., Feldmann, G., Rockstroh, J., Oldenburg, J., Kupfer, B., Sauerbruch, T. and Spengler, U. (2009), 'Effects of the CCR5-delta 32 mutation on hepatitis C virus-specific immune responses in patients with haemophilia', Immunological Investigations, vol 38, no 1 , pp 284 - 296.
• Mas Marques, A., Mueller, T., Welke, J., Taube, S., Sarrazin, C., Wiese, M., Halangk, J., Witt, H., Ahlenstiel, G., Spengler, U., Goebel, U., Schott, E., Weich, V., Schlosser, B., Wasmuth, H., Lammert, F., Berg, T. and Schreier, E. (2009), 'Low-density lipoprotein receptor variants are associated with spontaneous and treatment-induced recovery from hepatitis C virus infection', Infection, Genetics and Evolution, vol 9, no 5 , pp 847 - 852.
• Suppiah, V., Moldovan, M., Ahlenstiel, G., Berg, T., Weltman, M., Abate, M., Bassendine, M., Spengler, U., Dore, G., Powell, E., Riordan, S., Smedile, A., Fragomeli, V., Muller, T., Bahlo, M., Stewart, G., Booth, D. and George, J. (2009), 'IL28B is associated with response to chronic hepatitis C interferon-a and ribavirin therapy', Nature Genetics, vol 41, no 10 , pp 1100 - 1104.
• Nattermann, J., Vogel, M., Nischalke, H., Danta, M., Ahlenstiel, G., Michalk, M., Sauerbruch, T., Rockstroh, J. and Spengler, U. (2008), 'The TGF-? high producer genotype is associated with response to HCV-specific therapy in HIV-positive patients with acute hepatitis C', Journal of Hepatology, vol 48 , pp 305 - 306.
• Caggiari, L., De Zorzi, M., Ahlenstiel, G., Rehermann, B. and De Re, V. (2008), 'Identification of new major histocompatibility complex-A, -B, -C alleles in chimpanzees (Pan troglodytes)', Tissue Antigens, vol 72, no 1 , pp 79 - 83.
• Nattermann, J., Vogel, M., Nischalke, H., Danta, M., Ahlenstiel, G., Michalk, M., Sauerbruch, T., Rockstroh, J. and Spengler, U. (2008), 'The transforming growth factor-? high-producer genotype is associated with response to hepatitis C virus-specific therapy in HIV-positive patients with acute hepatitis C', AIDS, vol 22, no 11 , pp 1287 - 1292.
• Mix, H., Weiler-Normann, C., Thimme, R., Ahlenstiel, G., Shin, E., Herkel, J., David, C., Lohse, A. and Rehermann, B. (2008), 'Identification of CD4 T-cell epitopes in soluble liver antigen/liver pancreas autoantigen in autoimmune hepatitis', Gastroenterology, vol 135, no 6 , pp 2107 - 2118.
• De Zorzi, M., Caggiari, L., Ahlenstiel, G., Rehermann, B. and De Re, V. (2008), 'Description of two new major histocompatibility complex (MHC) class II DRB1 [Pan troglodytes (Patr)-DRB1] alleles', Tissue Antigens, vol 71, no 5 , pp 490 - 492.
• Ahlenstiel, G., Martin, M., Gao, X., Carrington, M. and Rehermann, B. (2008), 'Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses', Journal of Clinical Investigation, vol 118, no 3 , pp 1017 - 1026.
• Ahlenstiel, G., Nischalke, H., Bueren, K., Berg, T., Vogel, M., Biermer, M., Grunhage, F., Sauerbruch, T., Rockstroh, J., Spengler, U. and Nattermann, J. (2007), 'The GNB3 C825T polymorphism affects response to HCV therapy with pegylated interferon in HCV/HIV co-infected but not in HCV mono-infected patients', Journal of Hepatology, vol 47, no 3 , pp 348 - 355.